Genotypic and Phenotypic Detection of Multidrug-Resistant Mycobacterium Tuberculosis among HIV Patients Attending Tuberculosis Reference Centres in Northwest, Nigeria

In light of the escalating issue of tuberculosis resistance, it is imperative to consistently evaluate and examine therapeutic strategies. This study focus on genotypic and phenotypic detection of multidrug-resistant Mycobacterium tuberculosis among HIV patients attending tuberculosis reference centres in Northwest, Nigeria. A total of 503 sputum samples were collected aseptically among three referral facilities in Northwest using random sampling method. Molecular drug susceptibility testing was performed using Geno Type® MTBD Rplus assay. The overall prevalence was 4.3 %. The highest prevalence in relation to state was observed from Katsina (22.2 %) and the lowest was from Sokoto (3.6 %). The highest prevalence was observed among male patients (4.8%) while the female patients (3.4%). Age 66-70 yrs recorded the highest prevalence (100 %) and the lowest was 36-40 yrs and 41-45yrs (4.4 %). The highest resistance patterns were isolates from Kebbi were resistance to INH+ RIF+ FLQ (50.0 %) and the lowest was from Kaduna INH+ AMG (20.0 %). Routine TB testing among HIV patients must be improved to guide co-management

Multidrug-resistant, Mycobacterium tuberculosis, HIV patents

1. World Health Organization (WHO) (2013). Global Tuberculosis Report 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO. [Google Scholar] [Crossref]

2. Pokam, B.D.T., Dorothy, Y., Lovett, L., Prisca, W.G., Ruth, O., Laura, M., Nchawa, Y.Y., and Anne, E.A (2019). Molecular Analysis of Mycobacterium tuberculosis Isolated in the North Central Zone of Nigeria. Journal of Epidemiology and Global Health, 9(4):259–265 [Google Scholar] [Crossref]

3. World Health Organization. Treatment guidelines for multidrug- and rifampicin-resistant tuberculosis. 2018 update. Geneva: WHO press; 2018 [Google Scholar] [Crossref]

4. Abate D, Tedla Y, Meressa D and Ameni G (2014). Isoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment. The International Journal of tuberculosis and lung disease. 18(8):946–51 [Google Scholar] [Crossref]

5. Kehinde, A.O., and Adebiyi, E.O (2013). Molecular diagnosis of MDR-TB using GenoTypeMTBDRplus 96 assay in Ibadan, Nigeria. Niger. Journal of Physiology Science 187–191 [Google Scholar] [Crossref]

6. Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G (2015). Multidrug- resistant Mycobacterium tuberculosis and associated risk factors in Oromia region of Ethiopia. Inter J Infect Dis. 39:57–61 [Google Scholar] [Crossref]

7. Silaigwana B, Green E, Ndip R (2012). Molecular detection and drug resistance of Mycobacterium tuberculosis complex from cattle at a dairy farm in the Nkonkobe region of South Africa: a pilot study. Int J Environ Res Pub Heal.9:2045–56. [Google Scholar] [Crossref]

8. Daniel, J., Deb, C., Dubey, V.S., Sirakova, T.D., andAbomoelak, B (2016). Induction of a novel class of diacylglycerolacyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancylike state in culture. Journal Bacteriology 186(15): 5017-5030 [Google Scholar] [Crossref]

9. Suchindra, S., Brouwer, E.S and van Rie A (2019). Is HIV Infection a Risk Factor for Multidrug Resistant Tuberculosis? A Systemic Review. PlosOne. 4(5): 1-9 [Google Scholar] [Crossref]

10. Tadesse M, Aragaw D, Dimah B, Efa F, Abdella K, Kebede W, et al. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia. Inter-national journal of mycobacteriology. 2016; 5(2):185–91. [Google Scholar] [Crossref]

11. NTBLCP (2013) Guidelines on Programmatic and Clinical Management of Drug-Resistant TB. Organization and Practices in Tuberculosis Bacteriology. C.H Collins. Part II: TB smear microscopy (WHO/TB/98.258). Geneva: World Health Organization. Part II: TB smear microscopy (WHO/TB/98.258). Geneva: World Health Organization [Google Scholar] [Crossref]

12. Alelign A, Zewude A, Mohammed T, Tolosa S, Ameni G, Petros B (2019). Molecular detection of Mycobacte-rium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia. BMC infectious diseases. 19(1):343. [Google Scholar] [Crossref]

13. Biadglegne F, Sack U, Rodloff AC (2014). Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. Antimicrob Resist Infect Control. 3:31 [Google Scholar] [Crossref]

14. Getahun H., Gunneberg, C., Granich, R., & Nunn, P. (2010). The epidemiology and the response the co-epidemiology of TB and HIV and includes distributions of TB patients by HIV status across various settings. [Google Scholar] [Crossref]

15. Atif, M., Sulaiman, S. A. S., Shafie, A. A., Zaman, M. Q. U., & Asif, M. (2014). Treatment outcome of new and previously treated tuberculosis patients in Penang, Malaysia. Medical Laboratories - Requirements for Quality and Competence; International Standards medium. Tubercle. 43:439-433 [Google Scholar] [Crossref]

• Emerging Biologic Therapies in Autoimmune Diseases: Focus on Pemphigus Vulgaris, Generalized Myasthenia Gravis, and Psoriasis
• Monosodium Glutamate (MSG) Promotes the Contraction of Duodenal Visceral Smooth Muscle Ex Vivo in Rat
• Pleomorphic Adenoma of the Accessory Salivary Glands of the Nasopharynx: A Rare Location – Case Report and Literature Review
• Experiences of Medical Social Workers on Family Dynamics and Hospitalisation of Patients with Chronic Health Conditions at University College Hospital, Ibadan
• Effect of Short-Term Task-Oriented Rehabilitation on Pain and Disability in Post-Fracture Upper-Limb Malunion: A Single-Group Pre–Post Interventional Study